EU Pharma strategy provides unique moment to establish a regulatory pathway for Value Added Medicines and level the playing field with US

Brussels, 23 February 2021

The absence of a cohesive and unique regulatory framework for value added medicines in Europe acts to the detriment of patients and health care professionals across the continent. Gaps in the pharmaceutical legislation must be addressed to support off-patent innovation.

The European Committee for Standardization (CEN) is proud to announce the publication of EN 17444 “Doping prevention in sport - Good development and manufacturing practices aimed at preventing the presence of prohibited substances in food intended for sportspeople and food supplements”. It is the first European standard to prevent the presence

Advances in biomarker testing are having a transformative impact on cancer care, but Europe will have to overcome significant barriers in the equitable access and quality of these tests to realise their full potential, concludes an important new study released by the International Quality Network for Pathology (IQN Path), the E

Members of the S&D Group today called on the European Commission to ensure better protection of freedom for the press and the arts, during a remote meeting organised on ‘Media and Artistic Freedom Under Attack. Europe must act now!’